-
-
-
-
-
-
-
Pharvaris presents safety data on combined deucrictibant formulations
-
-
-
-
-
-
-
Pharvaris presents deucrictibant data at allergy conference
-
-
-
-
-
-
-
Pharvaris B.V. (PHVS) Stock Setup is Strong - Cantor Fitzgerald
-
-
-
-
-
-
-
Pharvaris delays RAPIDe-3 study results to Q4 2025
-
-
-
-
-
-
-
Pharvaris (PHVS) Presents Long-Term Clinical Data of Deucrictibant
-
-
-
-
-
-
-
Pharvaris (PHVS) Announces Data Highlighting Deucrictibant for the Treatment of HAE
-
-
-
-
-
435,406 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

